Related Experiment Video
Updated: Aug 17, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Do prior neurological comorbidities predict COVID-19 severity and death? A 25-month cross-sectional multicenter study
Mojtaba Sharafkhah1, Farah Moayedi2, Nozhan Alimi2
1Department of Neurology and Psychiatry, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Insights
Chronic neurological disorders (CNDs) significantly increase the risk of death and severity in COVID-19 patients. Early COVID-19 diagnosis is crucial for individuals with CNDs to improve outcomes.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- COVID-19 prognosis is worsened by comorbidities.
- The impact of chronic neurological disorders (CNDs) on COVID-19 outcomes remains unclear.
Purpose of the Study:
- To assess if CNDs predict in-hospital mortality or severity in COVID-19 patients.
Main Methods:
- Cross-sectional study of 7370 hospitalized COVID-19 patients (Feb 2020-Mar 2022).
- CND defined as neurological conditions causing permanent disability.
- Multivariate Cox-regression analyzed in-hospital mortality and COVID-19 severity.
Main Results:
- 1654 (22.4%) patients had CNDs, presenting with higher age and comorbidities.
- ICU admission (59.7% vs 20.3%) and mortality (43.4% vs 12.8%) were significantly higher in CND patients.
- CND independently predicted death (HR 1.198, p=0.003).
Conclusions:
- Chronic neurological disorders independently predict mortality and severity in COVID-19.
- Early COVID-19 diagnosis is recommended for patients with CNDs.
Background:
The prognosis of COVID-19 cases that suffer from particular comorbidities is worse. The impact of chronic neurological disorders (CNDs) on the outcome of COVID-19 patients is not clear yet. This study aimed to assess whether CNDs can predict in-hospital mortality or severity in COVID-19 patients.
Methods:
Following a cross-sectional design, all consecutive hospitalized patients with PCR-confirmed COVID-19 who were hospitalized at three centers from February 20th, 2020 to March 20th, 2022, were studied. CND was defined as neurological conditions resulting in permanent disability. Data on demographic and clinical characteristics, COVID-19 severity, treatment, and laboratory findings were evaluated. A multivariate Cox-regression log-rank test was used to assess the primary outcome, which was in-hospital all-cause mortality. The relationship among CND, COVID-19 severity and abnormal laboratory findings was analyzed as a secondary endpoint.
Results:
We studied 7370 cases, 43.6% female, with a mean age of 58.7 years. 1654 (22.4%) patients had one or more CNDs. Patients with CNDs had higher age, were more disabled at baseline, and had more vascular risk factors and comorbidities. The ICU admission rate in CND patients with 59.7% was more frequent than the figure among non-CND patients with 20.3% (p = 0.044). Mortality of those with CND was 43.4%, in comparison with 12.8% in other participants (p = 0.005). Based on the Cox regression analysis, CND could independently predict death (HR 1.198, 95% CI 1.023-3.298, p = 0.003).
Conclusion:
CNDs could independently predict the death and severity of COVID-19. Therefore, early diagnosis of COVID-19 should be considered in CND patients.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome III: Diagnostic Studies
Bias in Epidemiological Studies

